Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoko Kobayashi is active.

Publication


Featured researches published by Satoko Kobayashi.


Bioorganic & Medicinal Chemistry | 2008

The importance of CH/π hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase

Tomonaga Ozawa; Eiichi Tsuji; Motoyasu Ozawa; Chiaki Handa; Harunobu Mukaiyama; Toshihiro Nishimura; Satoko Kobayashi; Kosuke Okazaki

The interaction energy was calculated, by the ab initio FMO method, for complexes between LCK protein and four inhibitors (staurosporine, BMS compound 2, and our compounds 3 and 4). In every case a number of CH/pi hydrogen bonds have been disclosed in the so-called adenine pocket. In complexes of 2, 3, and 4, CH/pi and NH/pi hydrogen bonds have been observed in another pocket. In view of the above results, the aniline ring of 3 was replaced by 2,6-dimethyl aniline to increase the potency for LCK kinase. A 10-fold increase in the potency has been achieved for 4 over 3. We suggest that the concept of weak hydrogen bonds is useful in the rational design of drugs.


Bioorganic & Medicinal Chemistry | 2007

Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.

Harunobu Mukaiyama; Toshihiro Nishimura; Satoko Kobayashi; Tomonaga Ozawa; Noboru Kamada; Yoshimitsu Komatsu; Shinji Kikuchi; Hideki Oonota; Hiroshi Kusama


Bioorganic & Medicinal Chemistry | 2008

Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade

Harunobu Mukaiyama; Toshihiro Nishimura; Satoko Kobayashi; Yoshimitsu Komatsu; Shinji Kikuchi; Tomonaga Ozawa; Noboru Kamada; Hideki Ohnota


Chemical & Pharmaceutical Bulletin | 2007

Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke

Harunobu Mukaiyama; Toshihiro Nishimura; Hiroaki Shiohara; Satoko Kobayashi; Yoshimitsu Komatsu; Shinji Kikuchi; Eiichi Tsuji; Noboru Kamada; Hideki Ohnota; Hiroshi Kusama


Archive | 2006

Novel furopyridine derivative, pharmaceutical composition comprising the derivative, and use of the derivative or composition

Hiroaki Shiohara; Tetsuya Nakamura; Harunobu Mukaiyama; Satoko Kobayashi; Kazumichi Jo


Archive | 2008

Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition

Takehiro Ishikawa; Hitoshi Inoue; Satoko Kobayashi; Masako Yoshida; Hiroaki Shiohara; Yasunori Ueno; Nobuyuki Tanaka


Archive | 2008

Novel catechol derivative, pharmaceutical composition containing the same, and use of those

Hiroaki Shiohara; Takehiro Ishikawa; Satoko Kobayashi; Hitoshi Inoue; Masako Yoshida; Yasunori Ueno; Nobuyuki Tanaka


Archive | 2011

NEW CATECHOL-O-METHYLTRANSFERASE INHIBITOR

Hitoshi Inoue; Takehiro Ishikawa; Satoko Kobayashi; Nobuyuki Tanaka; Yasunori Ueno; Masako Yoshida; 康徳 上野; 仁史 井上; 正子 吉田; 聡子 小林; 信之 田中; 健宏 石川


Archive | 2009

Catechol derivative and its use

Takehiro Ishikawa; Satoko Kobayashi; Hitoshi Inoue; Yasunori Ueno; Masako Yoshida; Nobuyuki Tanaka


国際教育 = International education | 2015

「日本」をめぐるリベラル・アーツ教育の取組みとその意義 : 国際教育センター企画FD研修会(平成26年11月19日開催)の記録

聡子 小林; ヤニス ガイタニディス; Satoko Kobayashi; Ioannis Gaitanidis

Collaboration


Dive into the Satoko Kobayashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Kusama

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge